Table 1:
Perioperative patient characteristics
| Without fenestration (n = 108) | Fenestrated bend relief (n = 59) | P-value | |
|---|---|---|---|
| Age [years] | 58 (10.7) | 63 (10.6) | 0.002 |
| Male | 95 (88%) | 48 (81%) | 0.245 |
| ICM/DCM | 43 (40%)/57 (60%) | 35 (59%)/24 (41%) | 0.280 |
| INTERMACS | |||
| 1 | 24 (22%) | 16 (27%) | 0.776 |
| 2 | 17 (16%) | 11 (19%) | |
| 3 | 37 (34%) | 20 (34%) | |
| 4 | 30 (28%) | 12 (23%) | |
| Bridged with va-ECMO | 18 (17%) | 8 (14%) | 0.966 |
| DT/BTT | 46 (43%)/40 (37%) | 28 (47%)/11 (19%) | 0.037 |
| HMII/HM3 | 48 (44%)/60 (56%) | none/59 (100%) | <0.001 |
| Redo surgery | 29 (27%) | 14 (24%) | 0.647 |
| Full sternotomy | 102 (94%) | 59 (100%) | 0.088 |
| Outflow graft anastomosis | Ascending aorta, all cases | Ascending aorta, all cases | |
| Concomitant procedures | |||
| Tricuspid valve | 62 (57%) | 32 (54%) | 0.519 |
| Aortic valve | 6 (6%) | 11 (19%) | 0.008 |
| ASD/PFO closure | 16 (15%) | 5 (8%) | 0.201 |
| Temporary RVAD | 8 (7%) | 5 (8%) | 0.849 |
| LAA closure | 2 (1.9%) | 1 (21.7%) | 1.000 |
| CABG | 3 (2.7%) | 2 (3.4%) | 1.000 |
| Support duration | 951 (875) days (1–10 years) | 494 (383) days (0–4 years) | 0.022 |
| OGO | 5 (4.6%) | none | 0.163 |
Data are mean (standard deviation) or n (% of total).
ASD: atrial septal defect; BTT: bridge to transplant; CABG: coronary artery bypass grafting; DCM: dilatative cardiomyopathy; DT: destination therapy; HM 3: HeartMate 3™ (Abbott); HM II: HeartMate II™ (Abbott); ICM: ischaemic cardiomyopathy; INTERMACS: Interagency Registry for Mechanically Assisted Circulatory Support; LAA: left atrial appendage; PFO: patent foramen ovale; RVAD: right ventricular assist device; va-ECMO: veno-arterial extracorporeal membrane oxygenation.